Introduction
============

The PKCs comprise a family of intracellular serine/threonine kinases which are expressed in a cell type--specific pattern. PKCs have been shown to be involved in signal transduction of a wide range of biological responses including changes in cell morphology, proliferation, and differentiation ([@bib25]; [@bib1]). Typically, PKCs are lipid-activated kinases that can be distinguished by different lipid-dependent activation modes.

Two novel lipid-activated kinases, sharing significant homology to PKCs as well as to calmodulin-dependent kinases were identified in man and mouse and named PKCμ ([@bib14]) and PKD ([@bib26]), respectively. PKC homologies reside particularly in the NH~2~-terminal cysteine-rich zinc finger region, comprising the structural basis for lipid-mediated activation and the COOH-terminal kinase domain which exerts even closer homologies to the calmodulin kinases. However, PKCμ/PKD differ from the three major groups of PKC isozymes by the presence of a pleckstrin homology (PH)[\*](#fn1){ref-type="fn"} domain within the regulatory region ([@bib3]), an acidic domain ([@bib5]), and an NH~2~-terminal hydrophobic region. A PKC-typical pseudosubstrate site could not be identified. More recent work reported on novel PKCμ/PKD-related isotypes termed PKCν ([@bib9]) and PKD2 ([@bib24]), together defining a novel PKC-like kinase family.

PKCμ is ubiquitously expressed and apparently involved in diverse cellular functions, probably in a cell type--specific manner. For example, PKCμ shows particularly high expression in thymus and hematopoietic cells, suggesting a potential role in immune functions ([@bib22]; [@bib19]). In accordance with these studies is the finding that PKCμ is recruited together with the tyrosine kinase Syk and phospholipase Cγ to the B cell receptor complex upon B cell receptor stimulation and negatively regulates PLCγ activity ([@bib23]). Our previous studies further suggested a function in antiapoptotic signaling ([@bib13]). Probably the most intriguing finding is the Golgi compartment localization of PKCμ and involvement in constitutive transport processes in epithelial cells ([@bib21]). Indeed, very recent data point to a fundamental importance of PKCμ in G protein--mediated regulation of Golgi organization ([@bib11]) and initiation of vesicular transport processes at the TGN ([@bib17]).

In accordance with cell type--specific functions, PKCμ/PKD location and activation appears to differ in different cell types and may involve different upstream regulators, including conventional PKCs ([@bib29]; [@bib19]). For example, PKD activation by exogenous stimuli is mediated via a PKC-dependent pathway in murine mast cells and B cells ([@bib19]). Localization studies in the lymphocytic cell line A20 indicated a reversible, antigen receptor--triggered membrane translocation independent of the PKD PH domain ([@bib18]).

We have performed the present study to analyze in detail structural requirements for constitutive PKCμ localization at the Golgi compartment using the epithelial-derived HeLa cell line. We show that the NH~2~-terminal domain is essential for localization of PKCμ at the Golgi compartment and that intrinsic kinase activity is not necessary for this localization. Golgi complex attachment of PKCμ is required for phosphorylation of activation loop serines 738/742 and subsequent NH~2~-terminal phosphorylation at different serines. Overexpression of PKCμ--green fluorescent protein (GFP) mutants comprised of the Golgi localization domains only or of a kinase-dead variant, both acting as dominant negative inhibitors of endogenous PKCμ function, severely affected PKCμ localization, showing in addition to Golgi localization a localization in/at vesicle-like structures.

Results
=======

Characterization of PKCμ--GFP expression constructs
---------------------------------------------------

To analyze cellular localization of PKCμ in living cells, a set of plasmids was constructed expressing PKCμ mutants as COOH-terminal GFP fusion proteins. The mutants used in this study are schematically shown in [Fig. 1](#fig1){ref-type="fig"} (for details see Materials and methods). Mutants were transiently expressed in HEK293 cells to check expression by Western blot analyses and activity pattern by in vitro autophosphorylation of PKCμ immunoprecipitates ([Fig. 2](#fig2){ref-type="fig"}). GFP-tagged wild-type PKCμ and the kinase-dead PKCμ~K612W~-GFP mutant migrated with the expected relative molecular weight of ∼140 kD ([Fig. 2](#fig2){ref-type="fig"}, top), showing either basal autophosphorylation (wild-type) or a complete lack of kinase activity (PKCμ~K612W~-GFP, [Fig. 2](#fig2){ref-type="fig"}, bottom) as shown previously for wild-type PKCμ and the K612W kinase-dead mutant ([@bib13]). Several deletion mutants lacking either the PH domain (PKCμ~ΔPH~-GFP), the cysteine finger region (PKCμ~ΔCI~-GFP~,~ PKCμ~ΔCII~-GFP~,~ PKCμ~ΔCRD~-GFP), or the acidic region (PKCμ~ΔAD~-GFP) were expressed and analyzed in the same way by immunoprecipitation and autophosphorylation ([Fig. 2](#fig2){ref-type="fig"}). Interestingly, deletion of the acidic domain, which was predicted to be involved in regulation of PKCμ kinase activity ([@bib5]), resulted in enhancement of constitutive kinase activity, which was similar to that shown for the PKCμ~ΔPH~-GFP mutant ([Fig. 2](#fig2){ref-type="fig"}, bottom). Deletion of each of the cysteine fingers (Cys1: H147-C196, Cys2: H271-C320) or both did not affect PKCμ kinase activity ([Fig. 2](#fig2){ref-type="fig"}, bottom). NH~2~-terminal deletion mutants lacking either the first 78 amino acids, representing the hydrophobic region (PKCμ~Δ1--78~-GFP), or the 340 NH~2~-terminal amino acids (PKCμ~Δ1--340~-GFP), largely covering the zinc-finger region, were constructed and analyzed for protein expression as well as for kinase activity. PKCμ~Δ1--78~-GFP displayed a weak reduction in autophosphorylation efficiency, whereas enzyme activity of PKCμ~Δ1--340~-GFP was comparable to wild-type kinase activity ([Fig. 2](#fig2){ref-type="fig"}, bottom). As a control for localization and phosphorylation studies, the PH domain and the NH~2~-terminal domain (amino acids 1--325) were each separately expressed as a GFP fusion protein. As expected, these fragments, which lack the kinase domain, showed no autophosphorylation ([Fig. 2](#fig2){ref-type="fig"}, right lane, top and bottom; see [Fig. 6](#fig6){ref-type="fig"} A).

![**Schematic view of the PKC**μ**-GFP mutants used in this study.** The hydrophobic region (amino acids M1--D86) and the cysteine-rich region (CI and CII; amino acids H147--C196 and amino acids H271--C320) are located in the NH~2~-terminal domain of PKCμ. The PH domain (V409--T552) is located between CII and the COOH-terminal kinase domain. PKCμ~ΔPH~-GFP lacks the PH domain, whereas PKCμ~ΔCI~-GFP and PKCμ~ΔCII~-GFP lack the first or the second cysteine-rich region. In PKCμ~ΔCRD~-GFP both cysteine rich regions were deleted. PKCμ~Δ1--78~-GFP lacks the hydrophobic region (M1-R78), whereas PKCμ~1--86~-GFP contains only the hydrophobic regions of wild-type PKCμ. PKCμ~1--325~-GFP consists of 325 NH~2~-terminal amino acids. PKCμ~PH~ contains the PH domain (V409--T552). The acidic domain includes amino acids E336--D391. All mutants used in this study were expressed as COOH-terminal GFP fusion proteins as schematically indicated. Deleted domains are indicated by dashed lines. Phosphorylatable serine residues are indicated in wild-type PKCμ-GFP. AD, acidic domain; CRD, cysteine-rich domain; WT, wild-type. K612W indicates a point mutation in the ATP-binding site.](0110047f1){#fig1}

![**Expression and in vitro phosphorylation of PKC**μ**-GFP fusion proteins.** HEK293 cells were transfected with the indicated constructs. 40 h after transfection cells were lysed and PKCμ-GFP was immunoprecipitated using an anti-GFP antibody and subjected to Western blotting (top) and in vitro autophosphorylation (bottom). Shown are autoradiographs after overnight exposition.](0110047f2){#fig2}

###### 

**In vitro transphosphorylation of NH~2~-terminal PKC**μ **domains.** (A) Shown are in vitro kinase assays of GFP immunoprecipitates (top) after expression of the indicated PKCμ domains in HEK293 cells together with PKCμ-GFP or with vector controls. Expression of proteins was verified by Western blot analysis (bottom). (B) The NH~2~-terminal PKCμ domain is phosphorylated in intact cells. PKCμ~1--325~ was coexpressed with the indicated PKCμ-GFP mutants. Total cell lysates were analyzed for PKCμ~1--325~ expression using a mouse antiserum directed against the NH~2~-terminal domain (top) or a GFP antibody detecting PKCμ-GFP expression levels (bottom). (C) Ser~738/742~ activation loop phosphorylation is essential for NH~2~-terminal transphosphorylation. Wild-type PKCμ and the indicated mutants were expressed as GFP fusion proteins, immunoprecipitated, and subjected to in vitro kinase assays measuring either auto-, aldolase, or phosphorylation of PKCμ~1--325~-GFP (top). Expression of the PKCμ-GFP mutants was measured by Western blot analysis using an anti-GFP antibody (bottom).
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Identification of the binding domain mediating Golgi membrane association of PKCμ
---------------------------------------------------------------------------------

To specify determinants and functional activities relevant for subcellular localization, wild-type PKCμ-GFP and kinase-dead PKCμ~K612W~-GFP were expressed in HeLa cells and analyzed by confocal microscopy. For PKCμ-GFP a diffuse signal was revealed throughout the cell, but a clear enrichment in perinuclear structures was noted ([Fig. 3](#fig3){ref-type="fig"} A, top rows). Staining of endogenous PKCμ in HEK293 cells with PKCμ-specific antibodies verified that the PKCμ-GFP fusion protein does not differ in localization from endogenous PKCμ ([Fig. 3](#fig3){ref-type="fig"} D). These data are in accordance with previous studies ([@bib21]; [@bib17]). As a Golgi compartment--specific marker served p24, a vesicle and Golgi compartment--associated protein ([@bib4]). P24 appeared perinuclear and in vesicular structures throughout the cell ([Fig. 3](#fig3){ref-type="fig"}, middle). Partial colocalization of PKCμ-GFP with p24-positive compartments was verified by overlay ([Fig. 3](#fig3){ref-type="fig"} A, right). Further, costaining with antibodies specific for p230 ([@bib15]) and GM130 (unpublished data), independent markers of the trans- and cis Golgi network, respectively, verified Golgi compartment association of PKCμ ([Fig. 3](#fig3){ref-type="fig"} A). Interestingly, kinase-dead PKCμ~K612W~-GFP, although still partially colocalized with the Golgi markers at a perinuclear region, was found in structures dispersed throughout the cell with appearance of long tubuli and large vesicular structures ([Fig. 3](#fig3){ref-type="fig"} A, see enlargements). Of note, these PKCμ-positive structures did no longer costain with any of the three applied Golgi markers ([Fig. 3](#fig3){ref-type="fig"} A, right).

![**Subcellular localization of PKC**μ**-GFP mutants.** The indicated PKCμ-GFP mutants were transiently expressed in HeLa cells and analyzed by confocal laser scanning microscopy. 40 h after transfection cells were fixed and stained for p24 or p230 with an anti-p24 rabbit antiserum or an anti-p230 monoclonal antibody followed by an incubation with Alexa 546--labeled anti--rabbit or anti--mouse antibodies. Intact cell morphology was controlled by transmission light microscopy. PKCμ-GFP (green) and p24/p230 (red) stains were combined (right). The overlay is indicated by the yellow color. (A) Localization of wild-type PKCμ and a kinase-dead K612W mutant. (B) Localization of deletion mutants and selective domains. (C) Localization of NH~2~-terminal PKCμ deletion mutants and the respective NH~2~-terminal domains. Enlargement of the indicated section is shown. (D) Localization of endogenous PKCμ in HEK293 cells. Cells were stained with a PKCμ-specific antibody and with anti-GM130 as a Golgi compartment--specific marker.](0110047f3){#fig3}

Overexpression of a PKCμ mutant lacking kinase activity was shown recently to disrupt normal Golgi morphology, pointing to an essential role of kinase activity in maintaining Golgi structure ([@bib17]). Further corroborating this finding, we can show that not only expression of a kinase-dead PKCμ~K612W~-GFP, but also of the Golgi binding NH~2~-terminal fragment PKCμ~1--325~-GFP provoked changes in normal PKCμ localization, with signs of tubulation and/or large vesicle formation of PKCμ-positive structures ([Fig. 3, A and B](#fig3){ref-type="fig"}), suggesting a dominant negative action of both constructs on endogenous wild-type PKCμ. Using PKCμ~K612W~-GFP, we analyzed whether the observed morphological changes and segregation of PKCμ from p24-positive structures might also be associated with a relocation of PKCμ to different membrane compartments or other intracellular structures. Costaining of PKCμ~K612W~-GFP with various vesicular markers was analyzed. To this end, we could not detect any colocalization with EEA-1, Rab5, and Rab8 as endosomal markers. Furthermore, no colocalization with TGN38, BIP, Caveolin-1, Clathrin, or Lamp1 was detectable (unpublished data).

Although PH domains are frequently responsible for membrane association ([@bib2]), the deletion mutant of PKCμ showed no apparent differences in intracellular localization from the wild-type, and Golgi structure appeared normal ([Fig. 3](#fig3){ref-type="fig"} B). Moreover, analysis of the isolated PH domain expressed as a GFP fusion protein (PKCμ~PH~-GFP) revealed complete segregation from p24 staining and cytosolic/nuclear location ([Fig. 3](#fig3){ref-type="fig"} B). Contrary to the expectations, these data show that the PH domain is apparently not required for PKCμ association with the Golgi compartment. Likewise, a deletion of the acidic domain of PKCμ (PKCμ~ΔAD~-GFP) displayed enhanced basal kinase activity ([Fig. 2](#fig2){ref-type="fig"}) and did not interfere with Golgi compartment localization of PKCμ ([Fig. 3](#fig3){ref-type="fig"} B). Together, these data suggest that the PH and the acidic domain play a role in negative regulation of kinase activity rather than in localization.

The deletion of NH~2~-terminal regions affected Golgi compartment localization of PKCμ. As shown in [Fig. 3](#fig3){ref-type="fig"} C, expression of PKCμ-GFP mutants lacking either 78 (PKCμ~Δ1--78~-GFP) or 340 (PKCμ~Δ1--340~-GFP) NH~2~-terminal amino acids led to a complete cytosolic distribution of PKCμ. No colocalization with p24-staining structures was detectable ([Fig. 3](#fig3){ref-type="fig"} C). Deletion of the complete kinase domain did not affect Golgi compartment localization (unpublished data). An NH~2~-terminal PKCμ fragment (PKCμ~1--86~-GFP) was found to be located completely in the cytosol, whereas the entire NH~2~-terminal region covering both cysteine fingers (PKCμ~1--325~-GFP) showed partial colocalization with p24 staining structures ([Fig. 3](#fig3){ref-type="fig"} C). These data already suggest that the NH~2~-terminal hydrophobic region itself is not sufficient, but might be required in concert with the cysteine-rich domains to mediate Golgi complex association of PKCμ. The supposed important role of the cysteine-rich region was verified by expressing the respective deletion mutants. Deletion of either the second cysteine finger (PKCμ~ΔCII~-GFP) or the complete cysteine rich region (PKCμ~ΔCRD~-GFP); each resulted in cytosolic and nuclear distribution. In the case of PKCμ~ΔCI~-GFP, an exclusive nuclear localization was detected ([Fig. 3](#fig3){ref-type="fig"} C). These data identify the NH~2~-terminal hydrophobic domain and the adjacent zinc finger regions, together covering amino acids 1--325, as the Golgi compartment binding domain of PKCμ and demonstrate that intrinsic PKCμ kinase activity is not required for association with Golgi membranes.

Activation loop phosphorylation of PKCμ requires localization at the Golgi compartment
--------------------------------------------------------------------------------------

The data described above show the importance of the PKCμ NH~2~-terminal region for Golgi complex localization. As kinase-dead mutants of PKCμ-GFP remain associated with Golgi region ([Fig. 3](#fig3){ref-type="fig"} A) and other intracellular membranes ([@bib17]), and complete inhibition of kinase activity of wild-type PKCμ-GFP by H89 did not result in a relocation to the cytosol (unpublished data), it appears that autophosphorylation is not required for membrane recruitment of PKCμ. However, as upstream kinases appear to be involved in PKCμ activation, it was necessary to analyze in detail individual phosphorylation sites in PKCμ with respect to their role in Golgi localization and activation of the kinase.

To correlate localization with the phosphorylation state, the various PKCμ-GFP constructs used in this study were expressed in HEK293 cells and monitored for expression level as well as for in vivo PKCμ phosphorylation using PKCμ phosphosite--specific antibodies. As expected, constitutive PKCμ kinase activity was detected by pSer~910~-specific antibodies ([Fig. 4](#fig4){ref-type="fig"} A, middle). As a negative control, PKCμ~K612W~-GFP was included. No autophosphorylation was detectable with pSer~910~ antibodies. The pSer~738/742~ antibody detected the PKCμ~K612W~-GFP mutant, pointing to PKCμ kinase independent, constitutive phosphorylation of this site by an upstream kinase.

###### 

**Localization of PKC**μ**-GFP at the Golgi compartment is required for phosphorylation of serines 738/742.** (A) Differential phosphorylation of PKCμ-GFP deletion mutants. HEK293 cells were transfected with the indicated plasmids. Expression of the fusion proteins was monitored by Western blot analysis using an anti-GFP antibody. PKCμ-GFP phosphorylation was measured by phospho-specific antibodies recognizing phosphorylated Ser~738/742~ and Ser~910~. (B) Characterization of PKCμ-GFP phosphorylation mutants. (C) PKCμ~S738/742A~-GFP colocalizes with the Golgi compartment--specific marker p24. (D) PKCμ-GFP with phosphorylated activation loop is exclusively recovered in the organelle fraction. HEK293 cells were transfected with PKCμ-GFP or PKCμ~K612W~-GFP and separated into soluble proteins from organelles structures sedimenting at 100,000 *g*. Western blot analysis was performed by anti-GFP or phosphorylation-specific antibodies.
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Deletion mutants of the PH domain, the acidic region, or deletions of either the first, second, or both cysteine-rich regions showed phosphorylation of Ser~910~. As the NH~2~-terminal deletion mutants are cytosolic, while the former two are Golgi bound ([Fig. 3](#fig3){ref-type="fig"}), Ser~910~ autophosphorylation appears localization independent. In contrast, only the PKCμ~ΔPH~-GFP and the PKCμ~ΔAD~-GFP mutant exerted significant phosphorylation at Ser~738/742~ ([Fig. 4](#fig4){ref-type="fig"} A, bottom), whereas deletion mutants localized in the cytosol or in the nucleus show only weak phosphorylation at Ser~738/742~.

Five phosphorylation sites in PKCμ/PKD have been described recently ([@bib27]). As well as three phosphorylation sites in the COOH-terminal region, two phosphorylation sites at Ser~205~ (equivalent with Ser~203~ in PKD) and Ser~249~ (Ser~255~ in PKD) were reported. The NH~2~-terminal phosphorylation sites are likely to contribute to PKCμ activation and/or regulation of PKCμ.

To further determine phosphorylation-dependent influence on Golgi complex localization of PKCμ, all predicted phosphorylation sites (Ser~910~, Ser~738/742~, Ser~249~, Ser~205~) were mutated to alanine and characterized for activation loop and COOH terminal phosphorylation. As shown in [Fig. 4](#fig4){ref-type="fig"} B by Western blot analysis using phosphoserine-specific antibodies, mutations of NH~2~-terminal serine residues (S205A; S249A) did not influence phosphorylation sites on Ser~738/742~ or Ser~910~. Mutants of either Ser~738/742~ or Ser~910~ did effect detection by the respective antibodies, but did not influence other phosphorylation sites. Mutants were further analyzed for intracellular colocalization with p24. As shown for the Ser~738/742~Ala double mutation, Golgi complex localization ([Fig. 4](#fig4){ref-type="fig"} C) was not affected, indicating that phosphorylation of these activation loop sites is not a prerequisite for Golgi complex localization, but instead suggests that activation loop phosphorylation requires Golgi complex localization of PKCμ. All other phosphorylation site mutants analyzed showed similar localization as wild-type PKCμ-GFP (unpublished data).

In addition, intracellular distribution of PKCμ-GFP and PKCμ~K612W~-GFP was analyzed by biochemical methods. As shown in [Fig. 4](#fig4){ref-type="fig"} D, after separation of soluble proteins from organelles and structures phosphorylation of PKCμ in the activation loop was exclusively recovered in the organelle fraction, whereas PKCμ was recovered in both fractions ([Fig. 4](#fig4){ref-type="fig"} D). Phosphorylation of Ser~910~ was not affected by intracellular localization of PKCμ, as cytosolic and particular fractions contain approximately equal amounts of this phosphorylated species of PKCμ.

Golgi region--localized PKCμ is recruited from the cytosolic pool and is independent of activation loop phosphorylation. As shown by FRAP experiments ([Fig. 5](#fig5){ref-type="fig"}), cytosolic PKCμ-GFP and PKCμ~S738/742A~-GFP rapidly translocate to the Golgi region. Upon bleaching of Golgi region--localized PKCμ-GFP and PKCμ~S738/742A~-GFP within the circled area ([Fig. 5](#fig5){ref-type="fig"} A, right), specific GFP fluorescence disappears leaving only the cytosolic and vesicular pool of PKCμ within the cell ([Fig. 5](#fig5){ref-type="fig"} A, middle). Within a 15-min period, cytosolic PKCμ-GFP and PKCμ~S738/742A~-GFP are rapidly recruited to the Golgi region ([Fig. 5](#fig5){ref-type="fig"} A, right). As illustrated in [Fig. 5](#fig5){ref-type="fig"} B by the reverse experiment, i.e., bleaching of cytosolic PKCμ-GFP and PKCμ~S738/742A~-GFP, respectively, a decay of Golgi region--specific PKCμ-GFP and PKCμ~S738/742A~-GFP staining was found ([Fig. 5](#fig5){ref-type="fig"} B). Interestingly, in addition to an assumed cytosolic redistribution, which cannot be readily detected because of dilution of the fluorescence signal, we observed a redistribution of PKCμ-GFP, in particulate structures out of the defined region ([Fig. 5](#fig5){ref-type="fig"} B, enlargements). Of note, no difference between wild-type and activation loop mutant PKCμ-GFP was observed. These data clearly indicate a translocation of cytosolic PKCμ to the Golgi region independent of its activation loop phosphorylation and point to a constitutive attachment of PKCμ to Golgi membranes.

![**Constitutive recruitment of PKC**μ**~S738/742A~-GFP to the Golgi compartment.** (A) The Golgi pool of PKCμ-GFP recovers rapidly after photobleach independent of activation loop phosphorylation. The outlined area in the prebleach image (left) was photobleached. Pictures were taken after the indicated times shown in the middle and right panels. (B) Constitutive association of PKCμ-GFP with the Golgi compartment and membrane structures. Fluorescence outside of the marked region indicated in the prebleach image was eliminated by photobleaching. Note that the fluorescence intensity of PKCμ-GFP at the Golgi region is saturated in all of the images to allow visualization of less bright structures. Cells were preincubated with cycloheximide (20 μg/ml) for 2 h.](0110047f5){#fig5}

NH~2~-terminal phosphorylation is a consequence of activation loop phosphorylation of PKCμ at the Golgi compartment
-------------------------------------------------------------------------------------------------------------------

The above studies already suggested a multistep process of PKCμ activation with auto- and transphosphorylation events for the COOH-terminal--located phosphorylation sites. To decipher the sequence of phosphorylation events leading to activation and regulation of PKCμ, we established an in vitro transphosphorylation assay using several NH~2~-terminal PKCμ domains expressed as GFP fusion proteins as substrates for PKCμ-GFP. As shown in [Fig. 6](#fig6){ref-type="fig"} A, the PKCμ~1--325~-GFP domain could be efficiently phosphorylated by PKCμ-GFP, whereas the PKCμ~1--86~-GFP domain, as well as the PKCμ~PH~-GFP domain, were not phosphorylated by PKCμ-GFP. According to published data, the phosphorylation site was predicted to be Ser~205~ within the 14-3-3 binding site ([@bib8]) or Ser~249~ predicted to be phosphorylated by an upstream kinase ([@bib27]).

To further analyze whether the above-described NH~2~-terminal homologous transphosphorylation occurs in intact cells, PKCμ~1--325~ was coexpressed with wild-type or mutated PKCμ-GFP and analyzed by shift assays indicative of potential phosphorylation within this domain. As shown by Western blot analysis ([Fig. 6](#fig6){ref-type="fig"} B), coexpression of PKCμ~1--325~ together with PKCμ-GFP led to the appearance of two bands at the expected size of the fragment. The slower migrating band of PKCμ~1--325~ represents the phosphorylated protein which is evident from coexpression of PKCμ~1--325~ with kinase-dead PKCμ~K612W~-GFP, where only the faster migrating band appeared ([Fig. 6](#fig6){ref-type="fig"} B, top). Conversely, coexpression of constitutively active PKCμ~ΔPH~-GFP led to the exclusive appearance of the slower migrating band, indicating strong transphosphorylation of the NH~2~-terminal fragment. Interestingly, coexpression of PKCμ~ΔCRD~-GFP did not result in phosphorylation of PKCμ~1--325~. As shown above, this mutant lacks the Golgi localization domain and is therefore not phosphorylated at the activation loop Ser~738/742~. Accordingly, these findings suggest a stepwise activation by phosphorylation of Ser~910~ and Ser~738/742~ followed by NH~2~-terminal phosphorylation of PKCμ.

To confirm this sequential phosphorylation process, mutations in known phosphorylation sites (S205A, S249A, S738/S742A, S910A) were introduced in PKCμ-GFP, expressed, and analyzed by kinase assay for auto/trans- and substrate phosphorylation. Immunoprecipitates of PKCμ~S738/\ 742A~-GFP did not show detectable aldolase- or PKCμ~1--325~-GFP phosphorylation, whereas in the case of all other mutants, auto- and substrate phosphorylation was not affected ([Fig. 6](#fig6){ref-type="fig"} C). These data indicate that activation loop phosphorylation on Ser~738/742~ is essential for transphosphorylation of NH~2~-terminal residues.

Discussion
==========

In this study, we analyzed the structural basis for Golgi compartment localization of PKCμ in epithelial cells. Using a set of deletion mutants we can show by confocal microscopy that NH~2~-terminal residues covering amino acids 1--325 constitute the Golgi compartment localization domain. Moreover, we show that phosphorylation of PKCμ is not required for binding to Golgi membranes but rather that phosphorylation of Ser~738/742~ requires Golgi localization. Our data further suggest a sequence of events in which transphosphorylation of NH~2~-terminal epitopes occurs subsequent to activation loop phosphorylation, whereas autophosphorylation at Ser~910~ is independent of localization and of phosphorylation of the activation loop. The findings presented in this study are illustrated in a model shown in [Fig. 7](#fig7){ref-type="fig"}.

![**Model of recruitment to and activation of PKC**μ **at the Golgi compartment.**](0110047f7){#fig7}

PKCμ is comprised of several structural domains which are putatively able to mediate membrane interactions, such as a hydrophobic NH~2~ terminus and two cysteine-rich zinc finger regions, highly conserved among PKC members and shown to be involved in Golgi compartment localization of PKCε ([@bib16]), as well as a PH domain considered to mediate membrane association of proteins via binding to phosphatidylinositol phosphate ([@bib6]). Biochemical studies have recently shown that the hydrophobic region of PKD does not function as a genuine transmembrane domain ([@bib11]), which is underlined by our studies showing that the expression of the human homologous fragment does not, on its own, localize to membranes. However, the analysis of the various NH~2~-terminal deletion mutants of PKCμ provide direct evidence that this region is, in concert with both zinc fingers involved in Golgi compartment localization of PKCμ, whereas the PH domain, unexpected from its functional relevance for PKCμ activation at the Golgi complex, is not involved. The functional importance of the NH~2~-terminal region is further stressed by Golgi complex localization of overexpressed PKCμ~1--325~-GFP, resulting in a similar appearance of vesicular structures as expression of kinase-dead PKCμ ([Fig. 3](#fig3){ref-type="fig"}). This points to a dominant negative effect of this mutant by competition with endogenous PKCμ for binding to Golgi membranes and thus negatively affecting structure and potential functions in Golgi complex ([@bib17]).

The simultaneous requirement of the three subdomains within the NH~2~-terminal regulatory region for PKCμ association with Golgi membranes points to the need for multiple interactions. In addition to potential hydrophobic interactions via the NH~2~ terminus and lipid messenger binding to the zinc finger regions, protein--protein interactions of this PKCμ domain with integral or associated Golgi membrane proteins are likely to be involved. Although these Golgi membrane interaction partners of PKCμ have to be identified in further studies, the NH~2~-terminal region is already known to serve as a binding domain for regulatory proteins. For example, 14-3-3 proteins can bind to PKCμ and negatively regulate its kinase activity ([@bib8]). Other proteins, such as the tyrosine kinase Btk and lipid PI4- and PI4-5 kinases, were also shown to be associated with PKCμ via the NH~2~-terminal region ([@bib20]; [@bib12]). As the PI4-5 kinase does not associate with kinase-dead PKCμ, a role of phosphorylation-triggering association with this target protein was predicted ([@bib20]). From the studies presented here, for PKCμ binding to the Golgi region, an essential role of phosphorylation is ruled out, as evident e.g., from Golgi membrane localization of kinase-dead, kinase domain--deficient, and activation loop--deficient PKCμ. Accordingly, a role of PI4-5 kinase in serving as a Golgi region receptor of PKCμ appears very unlikely.

The PKCμ PH domain does not contribute to the localization at Golgi membranes. As deletion resulted in constitutive kinase activity, these data support a specific regulatory function of this domain ([@bib10]; [@bib7]) ([Fig. 2](#fig2){ref-type="fig"}). Of note, the PH domain has been shown to mediate the interaction with PKCη, which is thought to play a role in PKCμ activation ([@bib28]). The participation of the PH domain of the murine PKCμ homologue, PKD, in function at the Golgi region during G-protein signaling events has been demonstrated previously ([@bib11]). Our data clearly indicate that the PKCμ PH domain serves a regulatory function, probably by coupling to upstream pathways and, in contrast to classical PH domains, does not mediate membrane localization.

Our data also shed light on the sequence of events leading to activation of PKCμ. We provide evidence that activation of PKCμ is a complex process involving auto- and transphosphorylation events at Ser~910~ and Ser~738/742~, respectively, followed by phosphorylation of NH~2~-terminal residues. The role of the NH~2~-terminal phosphorylation is currently unclear. As it is performed through a homologous transphosphorylation event by activated PKCμ ([Fig. 6](#fig6){ref-type="fig"}) its function might be in the generation of phosphoepitopes mediating the binding of regulatory proteins such as 14-3-3 ([@bib8]) or of potential substrates such as PI kinases ([@bib20]). Within the domain between amino acids 200--250 a clustering of potential phosphorylation sites are located (12xSer, 4xThr). Therefore, it presently cannot be excluded that, dependent on the cellular context, different residues might be phosphorylated and thus may differentially influence activity of PKCμ.

As cellularly expressed kinase-dead PKCμ is phosphorylated on Ser~738/742~, these sides can be considered as transphosphorylation sites for an upstream kinase. This reasoning is supported by H89 inhibition of PKCμ kinase, demonstrating selective inhibition of phosphorylation of Ser~910~ and not of Ser~738/742~ (unpublished data). Therefore, our data point to an H89-insensitive upstream kinase. According to published data and our own observations, PKCμ is activated by upstream PKCs ([@bib29]). PKCη and also PKCε were recently implicated in PKD activation ([@bib28]). PKCε has been located at the Golgi compartment and a role in Golgi region--specific functions was suggested previously ([@bib16]). The data presented here are in accordance with a participation of PKCε in Golgi region functions via activation of PKCμ. In support of this, Golgi region localization domain mutants did not show phosphorylation on Ser~738/742~ ([Fig. 4](#fig4){ref-type="fig"} A). On the other hand, activation loop mutants, similarly to wild-type PKCμ, were localized at the Golgi region ([Fig. 4](#fig4){ref-type="fig"} C). This reemphasizes a phosphorylation-independent localization of PKCμ at the Golgi region and suggests PKCε as a candidate for an upstream kinase for activation loop phosphorylation of PKCμ at the Golgi compartment.

Materials and methods
=====================

Plasmid constructs and cell lines
---------------------------------

cDNA constructs containing wild-type and various mutant PKCμ sequences in the pCDNA3 mammalian expression vector have been described previously (PKCμ~K612W~, PKCμ~Δ1--78~, PKCμ~Δ1--340~, PKCμ~ΔAD~, and PKCμ~ΔPH~) ([@bib13], [@bib12]). Deletion of the CI motif, amino acids H147--C196 (PKCμ~ΔCI~); the CII motif, amino acids H271--C320 (PKCμ~ΔCII~); and the combination of both motifs (PKCμ~ΔCRD~) were generated by an overlap PCR using Taq-polymerase (MBI Fermentas). Site-specific mutations within PKCμ-GFP resulting in single amino acids substitutions (S205A, S249A, S738/742A, S910A) were performed by a PCR approach using the QuickChange site-directed mutagenesis system (Stratagene) according to the manufacturer\'s instructions. The integrity of the PCR-amplified plasmids were verified by sequencing. [Fig. 1](#fig1){ref-type="fig"} shows a scheme of the different mutants used in this study. The GFP-tagged wild-type and mutant PKCμ expression plasmids were obtained by subcloning the respective PKCμ coding sequence into the EcoRI-BamHI sites of the polylinker of the pEGFP-N1 vector from CLONTECH Laboratories, Inc. HeLa and HEK293 (American Type Culture Collection) were cultured in RPMI medium supplemented with 5% FCS.

Antibodies and reagents
-----------------------

Antibodies directed against phosphoSer~916~ and phosphoSer~744/748~ of PKD were purchased from NEB/Cell Signaling. p24-specific antibodies were provided by F. Wieland (University of Heidelberg, Heidelberg, Germany). Anti-GFP antibodies were obtained from Roche Diagnostics. Anti-p230 and anti-GM130 antibodies were purchased from Transduction Laboratories. Anti-PKCμ rabbit antibody was obtained from Santa Cruz Biotechnology, Inc. Secondary alkaline phosphatase conjugated goat anti-mouse IgG and goat anti-rabbit IgG antibodies were purchased from Dianova or Sigma-Aldrich. The Alexa 546--conjugated goat anti--rabbit and anti--mouse antibodies were purchased from Molecular Probes. Protease- and phosphatase inhibitors were from Biomol.

HEK293 and HeLa cell transfections
----------------------------------

HEK293 and HeLa cells were maintained at 37°C in a 5% CO~2~ atmosphere in RPMI medium supplemented with 5% FCS. The day before transfection, HEK293 cells were seeded at 3 × 10^5^ cells per well in a 6-well plate (for in vitro kinase assays and Western blot). HeLa cells were seeded at 5 × 10^4^ cells on glass coverslips (for immunofluorescence microscopy). DNA transfections (2 μg plasmid DNA per 3 × 10^5^ cells and 1 μg plasmid DNA per 5 × 10^4^ cells) were performed using Superfect reagent (QIAGEN) according to the manufacturer\'s instructions. In brief, appropriate DNA amounts were mixed with the Superfect reagent, incubated at room temperature for 10 min in order to allow the complex to form, and then directly added to the culture medium. 2--3 h later, cells were transferred to fresh RPMI supplemented medium and incubated for further 40 h at 37°C.

Immunoprecipitation and in vitro kinase assays
----------------------------------------------

HeLa and HEK293 cells transiently expressing the indicated PKCμ-GFP mutants were lysed at 4°C in lysis buffer (20 mM Tris/HCl, pH 7.4, 1% Triton X-100, 150 mM NaCl, 5 mM MgCl~2~, 1 mM NaF, 1 mM sodium orthovanadate, 10 μg/ml leupeptin, 0.5 mM PMSF). After 30 min cell lysis, the lysates were centrifuged (10,000 *g*, 15 min, 4°C), the supernatant was collected, and immunoprecipitation of GFP fusion proteins was performed with 400 ng of anti-GFP antibody. After a 1.5-h incubation at 4°C, 30 μl of protein G sepharose was added and the mixture was incubated at 4°C for 1 h. The sepharose pellet was then washed two times in lysis buffer and once in kinase buffer (50 mM Tris, pH 7.4, 10 mM MgCl~2~, 2 mM DTT) and PKCμ activity (as measured by auto- and substrate phosphorylation) was determined by incubating immunocomplexes with 10 μl of kinase buffer containing 2 μCi \[γ-^32^P\]-ATP with or without 5 μg aldolase at 37°C for 15 min. Reactions were terminated by the addition of 5× SDS-PAGE sample buffer and analyzed by SDS-PAGE, Western blotting, and autoradiography. Autoradiographs were analyzed by quantitative phosphoimage analysis (Molecular Dynamics).

Western blot analysis
---------------------

For Western blot analysis, transfected HEK293 cells were treated as described in the figure legends before being lysed in 200 μl lysis buffer followed by boiling with 5× SDS-PAGE sample buffer. Equal amounts of protein were loaded on a 12.5% SDS-PAGE. Upon fractionation, proteins were transferred to a nitrocellulose membrane (Schleicher & Schuell). Membranes were blocked, followed by incubation either with a monoclonal antibody against GFP (1:1,000), a mouse antiserum raised against the NH~2~-terminal region of PKCμ (1:1,000), or the rabbit antibodies phosphoSer744/748 and phosphoSer916 (both 1:500). Membranes were incubated with alkaline phosphatase--conjugated anti--mouse IgG or anti--rabbit IgG antibodies (1:5,000). Immunoblots were developed according to standard procedures.

For separation of soluble proteins from organelles 4 × 10^6^ HEK293 cells were transfected with 20 μg of pEGFP-N1-PKCμ or pEGFP-N1-PKCμ~K612W~ and 100 μl Superfect reagent (QIAGEN) according to the manufacturer\'s instructions. 40 h after transfection, cells were harvested and resuspended in 500 μl lysis buffer without Triton X-100. Homogenization was done by applying 20 strokes with a "very tight fitting" 5-ml Dounce homogenizator (Braun). To remove cellular debris, the cellular extract was centrifuged at 1000 *g* followed by centrifugation of the supernatant for 1 h at 100 000 *g* (TLA 100; Beckman Coulter). Soluble proteins were recovered in the supernatant, whereas organelles and structures were recovered in the pellet. The pellet was resuspended in lysis buffer. For Western blot analysis equal amounts of protein were loaded onto a 12.5% SDS-PAGE.

Confocal immunofluorescence analysis
------------------------------------

HeLa cells grown on glass coverslips and expressing the indicated GFP-tagged PKCμ mutants were washed once in PBS and fixed in 3.5% paraformaldehyde (pH 7.4) for 20 min at 37°C. Fixed cells were blocked and permeabilized in 5% normal goat serum and 0.05% Tween-20 for 30 min at room temperature. Coverslips were then incubated for 2 h at room temperature with the p24 rabbit antibody (1:200) or the p230 mouse antibody (1:200). Coverslips were washed three times in PBS and incubated with an anti--rabbit or an anti--mouse IgG Alexa 546--labeled antibody (1:500) for 1.5 h at room temperature. Cells were washed three times in PBS and mounted in Fluormount G (Dianova). Images were acquired using a confocal laser scanning microscope (TCS SP2; Leica) equipped with a 63×/1.4 HCX PlanAPO oil immersion objective. GFP was excited with an argon laser (488-nm line), whereas Alexa 546 was excited with a helium-neon laser (543-nm line). Each image represents a two-dimensional parallel projection of sections in the Z-series taken at 0.5--1-μm intervals across the depth of the cell.

Selective photobleaching was performed on the Leica TCS SP2 using 80 consecutive scans with a 488-nm laser line at full power. Live cells were held at 37°C and 5% CO~2~ atmosphere.
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